Para Advisors’s Gilead Sciences GILD Stock Holding History

Para Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-10,000	Closed	-$943K	–	31
2014 Q4	$943K	Buy	+10,000	New	+$1.03M	1.82%	17

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Para Advisors's GILD Position: Q1 2015 in Review

Para Advisors sold out of Gilead Sciences (GILD) in Q1 2015, closing a stake of 10,000 shares — an estimated $943K sold.

Para Advisors first reported a position in GILD in Q4 2014 and held it in 1 quarter. The position peaked at $943K in Q4 2014. 1,493 funds tracked by Wall St. Rank hold GILD as of Q1 2015.

Para Advisors reported no remaining Gilead Sciences position as of Q1 2015 after selling out during the quarter.
Para Advisors sold 10,000 Gilead Sciences shares in Q1 2015, an estimated $943K.
Para Advisors first reported a position in Gilead Sciences in Q4 2014 and held it in 1 quarter.
Para Advisors's Gilead Sciences position peaked at $943K in Q4 2014.
1,493 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2015.

Based on Para Advisors's 13F filing for Q1 2015, filed 15 May 2015.